Insights into ectodomain shedding and processing of protein-tyrosine pseudokinase 7 (PTK7)

Journal of Biological Chemistry

Volumn 287, Issue 50, 2012, Pages 42009-42018

  Golubkov, Vladislav S ^a   Strongin, Alex Y ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PROCESS; BIOLOGICAL SIGNIFICANCE; C-TERMINAL FRAGMENTS; CANCER CELLS; CANCER PROGRESSION; CELL INVASION; CELL POLARITY; ECTODOMAIN; ECTODOMAIN SHEDDING; EMBRYO DEVELOPMENT; HT-1080 CELLS; MEMBRANE TYPE-1 MATRIX METALLOPROTEINASE; MODEL SYSTEM; N-TERMINALS; PROTEASOMES; PROTEOLYTIC CLEAVAGE; PSEUDOKINASE; SECRETASES; WNT PATHWAY;

AMINO ACIDS; CYTOLOGY;

CELLS;

ADAM PROTEIN; GAMMA SECRETASE; MATRIX METALLOPROTEINASE 14; PHOSPHOTRANSFERASE; PROTEASOME; PROTEIN TYROSINE PSEUDOKINASE 7; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL INVASION; CELL NUCLEUS; CONTROLLED STUDY; ECTODOMAIN SHEDDING; FIBROSARCOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROCESSING;

ACTIVE TRANSPORT, CELL NUCLEUS; ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; CELL ADHESION MOLECULES; CELL LINE, TUMOR; FIBROSARCOMA; HUMANS; MATRIX METALLOPROTEINASE 14; NEOPLASM INVASIVENESS; PROTEIN STRUCTURE, TERTIARY; PROTEOLYSIS; RECEPTOR PROTEIN-TYROSINE KINASES; SOLUBILITY;

EID: 84871343626     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.371153     Document Type: Article

References (70)

1. Lu, X., Borchers, A. G., Jolicoeur, C., Rayburn, H., Baker, J. C., and Tessier-Lavigne, M. (2004) PTK7/CCK-4 is a novel regulator of planar cell polarity in vertebrates. Nature 430, 93-98 (Pubitemid 38915231)
2. Yen, W. W., Williams, M., Periasamy, A., Conaway, M., Burdsal, C., Keller, R., Lu, X., and Sutherland, A. (2009) PTK7 is essential for polarized cell motility and convergent extension during mouse gastrulation. Development 136, 2039-2048
3. Puppo, F., Thomé, V., Lhoumeau, A. C., Cibois, M., Gangar, A., Lembo, F., Belotti, E., Marchetto, S., Lécine, P., Prébet, T., Sebbagh, M., Shin, W. S., Lee, S. T., Kodjabachian, L., and Borg, J. P. (2011) Protein-tyrosine kinase 7 has a conserved role in Wnt/β-catenin canonical signalling. EMBO Rep. 12, 43-49
4. Winberg, M. L., Tamagnone, L., Bai, J., Comoglio, P. M., Montell, D., and Goodman, C. S. (2001) The transmembrane protein off-track associates with Plexins and functions downstream of Semaphorin signaling during axon guidance. Neuron 32, 53-62 (Pubitemid 32995889)
5. Peradziryi, H., Kaplan, N. A., Podleschny, M., Liu, X., Wehner, P., Borchers, A., and Tolwinski, N. S. (2011) PTK7/Otk interacts with Wnts and inhibits canonical Wnt signalling. EMBO J. 30, 3729-3740
6. Whitford, K. L., and Ghosh, A. (2001) Plexin signaling via off-track and rho family GTPases. Neuron 32, 1-3 (Pubitemid 32995882)
7. Toyofuku, T., Zhang, H., Kumanogoh, A., Takegahara, N., Yabuki, M., Harada, K., Hori, M., and Kikutani, H. (2004) Guidance of myocardial patterning in cardiac development by Sema6D reverse signalling. Nat. Cell Biol. 6, 1204-1211 (Pubitemid 39625119)
8. Shnitsar, I., and Borchers, A. (2008) PTK7 recruits dsh to regulate neural crest migration. Development 135, 4015-4024
9. Wehner, P., Shnitsar, I., Urlaub, H., and Borchers, A. (2011) RACK1 is a novel interaction partner of PTK7 that is required for neural tube closure. Development 138, 1321-1327
10. Lhoumeau, A. C., Puppo, F., Prébet, T., Kodjabachian, L., and Borg, J. P. (2011) PTK7. A cell polarity receptor with multiple facets. Cell Cycle 10, 1233-1236
11. Jung, J. W., Ji, A. R., Lee, J., Kim, U. J., and Lee, S. T. (2002) Organization of the human PTK7 gene encoding a receptor protein-tyrosine kinase-like molecule and alternative splicing of its mRNA. Biochim. Biophys. Acta 1579, 153-163 (Pubitemid 35341437)
12. Mossie, K., Jallal, B., Alves, F., Sures, I., Plowman, G. D., and Ullrich, A. (1995) Colon carcinoma kinase-4 defines a new subclass of the receptor tyrosine kinase family. Oncogene 11, 2179-2184
13. Gorringe, K. L., Boussioutas, A., and Bowtell, D. D. (2005) Novel regions of chromosomal amplification at 6p21, 5p13, and 12q14 in gastric cancer identified by array comparative genomic hybridization. Genes Chromosomes Cancer 42, 247-259 (Pubitemid 40171189)
14. Endoh, H., Tomida, S., Yatabe, Y., Konishi, H., Osada, H., Tajima, K., Kuwano, H., Takahashi, T., and Mitsudomi, T. (2004) Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction. J. Clin. Oncol. 22, 811-819 (Pubitemid 41103592)
15. Müller-Tidow, C., Schwäble, J., Steffen, B., Tidow, N., Brandt, B., Becker, K., Schulze-Bahr, E., Halfter, H., Vogt, U., Metzger, R., Schneider, P. M., Büchner, T., Brandts, C., Berdel, W. E., and Serve, H. (2004) High-throughput analysis of genome-wide receptor tyrosine kinase expression in human cancers identifies potential novel drug targets. Clin. Cancer Res. 10, 1241-1249 (Pubitemid 38365213)
16. Easty, D. J., Mitchell, P. J., Patel, K., Flørenes, V. A., Spritz, R. A., and Bennett, D. C. (1997) Loss of expression of receptor tyrosine kinase family genes PTK7 and SEK in metastatic melanoma. Int. J. Cancer 71, 1061-1065 (Pubitemid 27252891)
17. Su, Y. A., Yang, J., Tao, L., Nguyen, H., and He, P. (2010) Undetectable and decreased expression of KIAA1949 (Phostensin) encoded on chromosome 6p21.33 in human breast cancers revealed by transcriptome analysis. J. Cancer 1, 38-50
18. Piao, Z., Lee, K. S., Kim, H., Perucho, M., and Malkhosyan, S. (2001) Identification of novel deletion regions on chromosome arms 2q and 6p in breast carcinomas by amplotype analysis. Genes Chromosomes Cancer 30, 113-122 (Pubitemid 32044592)
19. Baudrier-Régnier, A., Bodenant, C., Proust, F., Delangre, T., Hemet, J., and Laquerrière, A. (2000) An isochromosome 6p in a primary meningeal malignant melanoma. Cancer Genet Cytogenet 119, 80-82
20. Duffy, M. J., McKiernan, E., O'Donovan, N., and McGowan, P. M. (2009) Role of ADAMs in cancer formation and progression. Clin. Cancer Res. 15, 1140-1144
21. Stocker, W., Grams, F., Baumann, U., Reinemer, P., Gomis-Ruth, F. X., McKay, D. B., and Bode, W. (1995) The metzincins-topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc peptidases. Protein Sci. 4, 823-840
22. Egeblad, M., and Werb, Z. (2002) New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161-174 (Pubitemid 37328786)
23. Itoh, Y., and Seiki, M. (2006) MT1-MMP. A potent modifier of pericellular microenvironment. J. Cell Physiol. 206, 1-8 (Pubitemid 41740711) ????????????????start here????????????????????
24. Morrison, C. J., Butler, G. S., Rodríguez, D., and Overall, C. M. (2009) Matrix metalloproteinase proteomics. Substrates, targets, and therapy. Curr. Opin. Cell Biol. 21, 645-653
25. Rodríguez, D., Morrison, C. J., and Overall, C. M. (2010) Matrix metalloproteinases. What do they not do? New substrates and biological roles identified by murine models and proteomics. Biochim. Biophys. Acta 1803, 39-54
26. Hotary, K., Li, X. Y., Allen, E., Stevens, S. L., and Weiss, S. J. (2006) A cancer cell metalloprotease triad regulates the basement membrane transmigration program. Genes Dev. 20, 2673-2686 (Pubitemid 44498378)
27. Hotary, K. B., Allen, E. D., Brooks, P. C., Datta, N. S., Long, M. W., and Weiss, S. J. (2003) Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 114, 33-45 (Pubitemid 36859839)
28. Hotary, K., Allen, E., Punturieri, A., Yana, I., and Weiss, S. J. (2000) Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J. Cell Biol. 149, 1309-1323 (Pubitemid 30399683)
29. Sabeh, F., Ota, I., Holmbeck, K., Birkedal-Hansen, H., Soloway, P., Balbin, M., Lopez-Otin, C., Shapiro, S., Inada, M., Krane, S., Allen, E., Chung, D., and Weiss, S. J. (2004) Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J. Cell Biol. 167, 769-781 (Pubitemid 39565156)
30. Belkin, A. M., Akimov, S. S., Zaritskaya, L. S., Ratnikov, B. I., Deryugina, E. I., and Strongin, A. Y. (2001) Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J. Biol. Chem. 276, 18415-18422
31. Kajita, M., Itoh, Y., Chiba, T., Mori, H., Okada, A., Kinoh, H., and Seiki, M. (2001) Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J. Cell Biol. 153, 893-904 (Pubitemid 34289231)
32. v subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase. J. Biol. Chem. 277, 9749-9756
33. Rozanov, D. V., Savinov, A. Y., Williams, R., Liu, K., Golubkov, V. S., Krajewski, S., and Strongin, A. Y. (2008) Molecular signature of MT1-MMP. Transactivation of the downstream universal gene network in cancer. Cancer Res. 68, 4086-4096
34. Seiki, M., Koshikawa, N., and Yana, I. (2003) Role of pericellular proteolysis by membrane-type 1 matrix metalloproteinase in cancer invasion and angiogenesis. Cancer Metastasis Rev. 22, 129-143 (Pubitemid 36561053)
35. Rowe, R. G., Li, X. Y., Hu, Y., Saunders, T. L., Virtanen, I., Garcia de Herreros, A., Becker, K. F., Ingvarsen, S., Engelholm, L. H., Bommer, G. T., Fearon, E. R., and Weiss, S. J. (2009) Mesenchymal cells reactivate Snail1 expression to drive three-dimensional invasion programs. J. Cell Biol. 184, 399-408
36. Szabova, L., Chrysovergis, K., Yamada, S. S., and Holmbeck, K. (2008) MT1-MMP is required for efficient tumor dissemination in experimental metastatic disease. Oncogene 27, 3274-3281 (Pubitemid 351733384)
37. Holmbeck, K., Bianco, P., Yamada, S., and Birkedal-Hansen, H. (2004) MT1-MMP. A tethered collagenase. J. Cell Physiol. 200, 11-19
38. Holmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer, M., Kuznetsov, S. A., Mankani, M., Robey, P. G., Poole, A. R., Pidoux, I., Ward, J. M., and Birkedal-Hansen, H. (1999) MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99, 81-92 (Pubitemid 29468632)
39. Mochizuki, S., and Okada, Y. (2007) ADAMs in cancer cell proliferation and progression. Cancer Sci. 98, 621-628 (Pubitemid 46563436)
40. Murphy, G. (2009) Regulation of the proteolytic disintegrin metalloproteinases, the "Sheddases." Semin. Cell Dev. Biol. 20, 138-145
41. Duffy, M. J., Mullooly, M., O'Donovan, N., Sukor, S., Crown, J., Pierce, A., and McGowan, P. M. (2011) The ADAMs family of proteases. New biomarkers and therapeutic targets for cancer? Clin. Proteomics 8, 9
42. Brew, K., and Nagase, H. (2010) The tissue inhibitors of metalloproteinases (TIMPs). An ancient family with structural and functional diversity. Biochim. Biophys. Acta 1803, 55-71
43. Golubkov, V. S., Aleshin, A. E., and Strongin, A. Y. (2011) Potential relation of aberrant proteolysis of human protein-tyrosine kinase 7 (PTK7) chuzhoi by membrane type 1 matrix metalloproteinase (MT1-MMP) to congenital defects. J. Biol. Chem. 286, 20970-20976
44. Golubkov, V. S., Chekanov, A. V., Cieplak, P., Aleshin, A. E., Chernov, A. V., Zhu, W., Radichev, I. A., Zhang, D., Dong, P. D., and Strongin, A. Y. (2010) The Wnt/planar cell polarity protein-tyrosine kinase-7 (PTK7) is a highly efficient proteolytic target of membrane type-1 matrix metalloproteinase. Implications in cancer and embryogenesis. J. Biol. Chem. 285, 35740-35749
45. Sounni, N. E., Rozanov, D. V., Remacle, A. G., Golubkov, V. S., Noel, A., and Strongin, A. Y. (2010) Timp-2 binding with cellular MT1-MMP stimulates invasion-promoting MEK/ERK signaling in cancer cells. Int. J. Cancer 126, 1067-1078
46. Golubkov, V. S., Boyd, S., Savinov, A. Y., Chekanov, A. V., Osterman, A. L., Remacle, A., Rozanov, D. V., Doxsey, S. J., and Strongin, A. Y. (2005) Membrane type-1 matrix metalloproteinase (MT1-MMP) exhibits an important intracellular cleavage function and causes chromosome instability. J. Biol. Chem. 280, 25079-25086 (Pubitemid 40934599)
47. Golubkov, V. S., Chekanov, A. V., Savinov, A. Y., Rozanov, D. V., Golubkova, N. V., and Strongin, A. Y. (2006) Membrane type-1 matrix metalloproteinase confers aneuploidy and tumorigenicity on mammary epithelial cells. Cancer Res. 66, 10460-10465 (Pubitemid 44799767)
48. Kveiborg, M., Instrell, R., Rowlands, C., Howell, M., and Parker, P. J. (2011) PKCα and PKCδ regulate ADAM17-mediated ectodomain shedding of heparin binding-EGF through separate pathways. PLoS One 6, e17168
49. Kohutek, Z. A., diPierro, C. G., Redpath, G. T., and Hussaini, I. M. (2009) ADAM-10-mediated N-cadherin cleavage is protein kinase Cα dependent and promotes glioblastoma cell migration. J. Neurosci. 29, 4605-4615
50. Sundberg, C., Thodeti, C. K., Kveiborg, M., Larsson, C., Parker, P., Albrechtsen, R., and Wewer, U. M. (2004) Regulation of ADAM12 cell-surface expression by protein kinase Cε. J. Biol. Chem. 279, 51601-51611 (Pubitemid 40017911)
51. Le Gall, S. M., Auger, R., Dreux, C., and Mauduit, P. (2003) Regulated cell surface pro-EGF ectodomain shedding is a zinc metalloprotease-dependent process. J. Biol. Chem. 278, 45255-45268 (Pubitemid 37432660)
52. Guo, S., Liu, M., and Gonzalez-Perez, R. R. (2011) Role of Notch and its oncogenic signaling crosstalk in breast cancer. Biochim. Biophys. Acta 1815, 197-213
53. Killar, L., White, J., Black, R., and Peschon, J. (1999) Adamalysins. A family of metzincins including TNF-α converting enzyme (TACE). Ann. N.Y. Acad. Sci. 878, 442-452 (Pubitemid 29353587)
54. Yañez-Mó, M., Sánchez-Madrid, F., and Cabañas, C. (2011) Membrane proteases and tetraspanins. Biochem. Soc. Trans. 39, 541-546
55. Lichtenthaler, S. F., Haass, C., and Steiner, H. (2011) Regulated intramembrane proteolysis. Lessons from amyloid precursor protein processing. J. Neurochem. 117, 779-796
56. Montes de Oca-B., P. (2010) Ectdomain shedding and regulated intracellular proteolysis in the central nervous system. Cent. Nerv. Syst. Agents Med. Chem. 10, 337-359
57. Zolkiewska, A. (2008) ADAM proteases. Ligand processing and modulation of the Notch pathway. Cell Mol. Life Sci. 65, 2056-2068
58. Na, H. W., Shin, W. S., Ludwig, A., and Lee, S. T. (2012) The cytosolic domain of protein-tyrosine kinase 7 (PTK7), generated from sequential cleavage by a disintegrin and metalloprotease 17 (ADAM17) and γ-secretase, enhances cell proliferation and migration in colon cancer cells. J. Biol. Chem. 287, 25001-25009
59. Fenteany, G., and Schreiber, S. L. (1998) Lactacystin, proteasome function, and cell fate. J. Biol. Chem. 273, 8545-8548 (Pubitemid 28176125)
60. Amour, A., Knight, C. G., Webster, A., Slocombe, P. M., Stephens, P. E., Knäuper, V., Docherty, A. J., and Murphy, G. (2000) The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. FEBS Lett. 473, 275-279 (Pubitemid 30249139)
61. Zhao, H., Bernardo, M. M., Osenkowski, P., Sohail, A., Pei, D., Nagase, H., Kashiwagi, M., Soloway, P. D., DeClerck, Y. A., and Fridman, R. (2004) Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation. J. Biol. Chem. 279, 8592-8601 (Pubitemid 38295913)
62. Lin, E. A., and Liu, C. J. (2010) The role of ADAMTSs in arthritis. Protein Cell 1, 33-47
63. Lim, N. H., Kashiwagi, M., Visse, R., Jones, J., Enghild, J. J., Brew, K., and Nagase, H. (2010) Reactive-site mutants of N-TIMP-3 that selectively inhibit ADAMTS-4 and ADAMTS-5. Biological and structural implications. Biochem. J. 431, 113-122
64. Kwak, H. I., Mendoza, E. A., and Bayless, K. J. (2009) ADAM17 co-purifies with TIMP-3 and modulates endothelial invasion responses in three-dimensional collagen matrices. Matrix Biol. 28, 470-479
65. Jones, G. C., and Riley, G. P. (2005) ADAMTS proteinases. A multi-domain, multi-functional family with roles in extracellular matrix turnover and arthritis. Arthritis Res. Ther. 7, 160-169 (Pubitemid 40936607)
66. Amour, A., Knight, C. G., English, W. R., Webster, A., Slocombe, P. M., Knäuper, V., Docherty, A. J., Becherer, J. D., Blobel, C. P., and Murphy, G. (2002) The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs. FEBS Lett. 524, 154-158 (Pubitemid 34804852)
67. Bigg, H. F., Morrison, C. J., Butler, G. S., Bogoyevitch, M. A., Wang, Z., Soloway, P. D., and Overall, C. M. (2001) Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase. Cancer Res. 61, 3610-3618 (Pubitemid 32694971)
68. Lee, M. H., Rapti, M., and Murphy, G. (2005) Total conversion of tissue inhibitor of metalloproteinase (TIMP) for specific metalloproteinase targeting. Fine-tuning TIMP-4 for optimal inhibition of tumor necrosis factor-α- converting enzyme. J. Biol. Chem. 280, 15967-15975 (Pubitemid 40616720)
69. Zhou, B. B., Peyton, M., He, B., Liu, C., Girard, L., Caudler, E., Lo, Y., Baribaud, F., Mikami, I., Reguart, N., Yang, G., Li, Y., Yao, W., Vaddi, K., Gazdar, A. F., Friedman, S. M., Jablons, D. M., Newton, R. C., Fridman, J. S., Minna, J. D., and Scherle, P. A. (2006) Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer. Cancer Cell 10, 39-50 (Pubitemid 44018087)
70. Fridman, J. S., Caulder, E., Hansbury, M., Liu, X., Yang, G., Wang, Q., Lo, Y., Zhou, B. B., Pan, M., Thomas, S. M., Grandis, J. R., Zhuo, J., Yao, W., Newton, R. C., Friedman, S. M., Scherle, P. A., and Vaddi, K. (2007) Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancer. Clin. Cancer Res. 13, 1892-1902 (Pubitemid 46952960)